PCM
CVS icon

Patient Capital Management’s CVS Health CVS Stock Holding History

Patient Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Sell
1,235,505
-121,654
-9% -$10.9M 4.19% 7
2026
Q1 		$97.5M Buy
1,357,159
+125,743
+10% +$9.69M 3.56% 13
2025
Q4 		$97.7M Sell
1,231,416
-8,478
-0.7% -$668K 3.77% 10
2025
Q3 		$93.5M Sell
1,239,894
-2,030
-0.2% -$139K 3.74% 10
2025
Q2 		$85.7M Sell
1,241,924
-83,714
-6% -$5.49M 3.87% 9
2025
Q1 		$89.8M Buy
1,325,638
+27,209
+2% +$1.63M 4.62% 7
2024
Q4 		$58.3M Buy
1,298,429
+529,333
+69% +$29.7M 2.69% 21
2024
Q3 		$48.4M Buy
769,096
+29,387
+4% +$1.71M 2.37% 21
2024
Q2 		$43.7M Buy
739,709
+167,135
+29% +$10.5M 2.32% 21
2024
Q1 		$45.7M Sell
572,574
-28,403
-5% -$2.17M 2.22% 23
2023
Q4 		$47.5M Sell
600,977
-4,143
-0.7% -$295K 2.51% 15
2023
Q3 		$42.2M Buy
+605,120
New +$42.9M 2.48% 20

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Patient Capital Management's CVS Position: Q2 2026 in Review

Patient Capital Management reduced its CVS Health (CVS) stake by 9% in Q2 2026, selling an estimated $10.9M and leaving 1,235,505 shares worth $128M. The position accounts for 4.19% of the portfolio, ranked #7.

Patient Capital Management first reported a position in CVS in Q3 2023 and has held it in 12 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Patient Capital Management held 1,235,505 shares of CVS Health worth $128M as of Q2 2026.
  • Patient Capital Management sold 121,654 CVS Health shares in Q2 2026, an estimated $10.9M.
  • CVS Health made up 4.19% of Patient Capital Management's portfolio in Q2 2026, its #7 holding.
  • Patient Capital Management first reported a position in CVS Health in Q3 2023 and has held it in 12 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.